Chengzhi Shareholding Co Ltd (SHE:000990) — Market Cap & Net Worth
Market Cap & Net Worth: Chengzhi Shareholding Co Ltd (000990)
Chengzhi Shareholding Co Ltd (SHE:000990) has a market capitalization of $1.58 Billion (CN¥10.80 Billion) as of September 17, 2026. Listed on the SHE stock exchange, this China-based company holds position #7035 globally and #1470 in its home market, demonstrating a -2.76% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chengzhi Shareholding Co Ltd's stock price CN¥6.35 by its total outstanding shares 1701332549 (1.70 Billion). Also see Chengzhi Shareholding Co Ltd balance sheet assets for a full breakdown of the balance sheet.
Chengzhi Shareholding Co Ltd Market Cap History: 2015 to 2026
Chengzhi Shareholding Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $5.99 Billion to $1.58 Billion (-11.28% CAGR). Also see Chengzhi Shareholding Co Ltd operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Chengzhi Shareholding Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Chengzhi Shareholding Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 000990 stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.18x
Chengzhi Shareholding Co Ltd's market cap is 0.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $3.66 Billion | $2.57 Billion | $110.78 Million | 1.42x | 33.06x |
| 2017 | $4.08 Billion | $5.69 Billion | $808.51 Million | 0.72x | 5.05x |
| 2018 | $2.87 Billion | $5.87 Billion | $849.32 Million | 0.49x | 3.38x |
| 2019 | $3.62 Billion | $6.91 Billion | $442.55 Million | 0.52x | 8.17x |
| 2020 | $2.89 Billion | $9.73 Billion | $355.08 Million | 0.30x | 8.15x |
| 2021 | $3.86 Billion | $12.18 Billion | $1.01 Billion | 0.32x | 3.83x |
| 2022 | $2.15 Billion | $11.72 Billion | $50.93 Million | 0.18x | 42.16x |
| 2023 | $2.03 Billion | $12.42 Billion | $177.40 Million | 0.16x | 11.45x |
| 2024 | $1.93 Billion | $11.07 Billion | $230.59 Million | 0.17x | 8.37x |
| 2025 | $1.97 Billion | $11.03 Billion | -$78.14 Million | 0.18x | N/A |
Competitor Companies of 000990 by Market Capitalization
Companies near Chengzhi Shareholding Co Ltd in the global market cap rankings as of September 17, 2026. Review 000990 tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Chengzhi Shareholding Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #186 globally with a market cap of $130.44 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #353 globally with a market cap of $78.29 Billion USD.
- CSL Ltd (AU:CSL): Ranked #457 globally with a market cap of $59.82 Billion USD ( AU$84.54 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #506 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #186 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.44 Billion | $514.63 |
| #353 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $78.29 Billion | $774.11 |
| #457 | CSL Ltd | AU:CSL | $59.82 Billion | AU$174.26 |
| #506 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $143.77 |
Chengzhi Shareholding Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Chengzhi Shareholding Co Ltd's market cap moved from $5.99 Billion to $ 1.58 Billion, with a yearly change of -11.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.58 Billion | -19.82% |
| 2025 | CN¥1.97 Billion | +2.19% |
| 2024 | CN¥1.93 Billion | -5.01% |
| 2023 | CN¥2.03 Billion | -5.39% |
| 2022 | CN¥2.15 Billion | -44.37% |
| 2021 | CN¥3.86 Billion | +33.39% |
| 2020 | CN¥2.89 Billion | -19.97% |
| 2019 | CN¥3.62 Billion | +25.99% |
| 2018 | CN¥2.87 Billion | -29.65% |
| 2017 | CN¥4.08 Billion | +11.39% |
| 2016 | CN¥3.66 Billion | -38.91% |
| 2015 | CN¥5.99 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Chengzhi Shareholding Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.58 Billion USD |
| MoneyControl | $1.58 Billion USD |
| MarketWatch | $1.58 Billion USD |
| marketcap.company | $1.58 Billion USD |
| Reuters | $1.58 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Chengzhi Shareholding Co Ltd
Chengzhi Co., Ltd. engages in the clean energy, semiconductor display material, and healthcare and life science businesses in China. The company produces and sells gas products, including carbon monoxide, purified gas, and syngas, as well as industrial chemical products, such as methanol, ethylene, and butanol. It also processes materials comprising TN type, STN type, and TFT type; and glass proc… Read more